{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T05:24:15Z","timestamp":1784352255321,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2021]]},"DOI":"10.6061\/clinics\/2021\/e2324","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T07:21:54Z","timestamp":1611127314000},"page":"e2324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The mutational repertoire of uterine sarcomas and carcinosarcomas in a Brazilian cohort: A preliminary study"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6450-3825","authenticated-orcid":false,"given":"Leonardo Tomiatti","family":"da Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9027-8281","authenticated-orcid":false,"given":"Laura Gonzalez","family":"dos Anjos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1706-0950","authenticated-orcid":false,"given":"Luciane Tsukamoto","family":"Kagohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8659-5329","authenticated-orcid":false,"given":"Giovana Tardin","family":"Torrezan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6183-2933","authenticated-orcid":false,"given":"Claudia A. Andrade","family":"De Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0111-9030","authenticated-orcid":false,"given":"Edmund Chada","family":"Baracat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5667-1418","authenticated-orcid":false,"given":"Dirce Maria","family":"Carraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7295-678X","authenticated-orcid":false,"given":"Katia Candido","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.6061\/clinics\/2021\/e2324_bib1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.tjog.2016.04.033","article-title":"Uterine sarcoma Part I-Uterine leiomyosarcoma: The Topic Advisory Group systematic review","volume":"55","author":"Wen","year":"2016","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.6061\/clinics\/2021\/e2324_bib2","series-title":"Female Genital Tumours","volume":"vol. 4","author":"WHO Classification of Tumours Editorial Board","year":"2020"},{"issue":"9","key":"10.6061\/clinics\/2021\/e2324_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3390\/cancers10090315","article-title":"Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?","volume":"10","author":"Gonzalez Dos Anjos","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"Suppl 2","key":"10.6061\/clinics\/2021\/e2324_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ijgo.12613","article-title":"Uterine sarcomas","volume":"143","author":"Mbatani","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"10.6061\/clinics\/2021\/e2324_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/vaccines6030056","article-title":"Endometrial Stromal Sarcomas: A Revision of Their Potential as Targets for Immunotherapy","volume":"6","author":"Tuyaerts","year":"2018","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"10.6061\/clinics\/2021\/e2324_bib6","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.18632\/oncotarget.13270","article-title":"The JAZF1-SUZ12 fusion protein disrupts PRC2 complexes and impairs chromatin repression during human endometrial stromal tumorogenesis","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"key":"10.6061\/clinics\/2021\/e2324_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13023-016-0400-8","article-title":"JAZF1\/SUZ12 gene fusion in endometrial stromal sarcomas","volume":"11","author":"Hrzenjak","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"10.6061\/clinics\/2021\/e2324_bib8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/gcc.22845","article-title":"A novel MBTD1-PHF1 gene fusion in endometrial stromal sarcoma: A case report and literature review","volume":"59","author":"Han","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"issue":"12","key":"10.6061\/clinics\/2021\/e2324_bib9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/gcc.22485","article-title":"Fusion of the genes BRD8 and PHF1 in endometrial stromal sarcoma","volume":"56","author":"Micci","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.6061\/clinics\/2021\/e2324_bib10","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/ijc.28440","article-title":"Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma","volume":"134","author":"Dewaele","year":"2014","journal-title":"Int J Cancer"},{"issue":"32","key":"10.6061\/clinics\/2021\/e2324_bib11","doi-asserted-by":"crossref","first-page":"33319","DOI":"10.18632\/oncotarget.5384","article-title":"Genomic landscape of endometrial stromal sarcoma of uterus","volume":"6","author":"Choi","year":"2015","journal-title":"Oncotarget"},{"issue":"12","key":"10.6061\/clinics\/2021\/e2324_bib12","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S1470-2045(09)70226-8","article-title":"Clinical management of uterine sarcomas","volume":"10","author":"Amant","year":"2009","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.6061\/clinics\/2021\/e2324_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejrad.2010.12.057","article-title":"Uterine sarcomas\u2013recent progress and future challenges","volume":"78","author":"Seddon","year":"2011","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.6061\/clinics\/2021\/e2324_bib14","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3892\/mco.2013.124","article-title":"The biology of uterine sarcomas: A review and update","volume":"1","author":"Kobayashi","year":"2013","journal-title":"Mol Clin Oncol"},{"issue":"4","key":"10.6061\/clinics\/2021\/e2324_bib15","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cell.2017.10.014","article-title":"Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas","volume":"171","author":"Cancer Genome Atlas Research Network Cancer Genome Atlas Research Network","year":"2017","journal-title":"Cell"},{"issue":"6","key":"10.6061\/clinics\/2021\/e2324_bib16","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/cas.13613","article-title":"Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma","volume":"109","author":"Tsuyoshi","year":"2018","journal-title":"Cancer Sci"},{"issue":"3","key":"10.6061\/clinics\/2021\/e2324_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccell.2017.02.010","article-title":"Integrated Molecular Characterization of Uterine Carcinosarcoma","volume":"31","author":"Cherniack","year":"2017","journal-title":"Cancer Cell"},{"issue":"2","key":"10.6061\/clinics\/2021\/e2324_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41379-018-0132-5","article-title":"DICER1 mutations are frequent in m\u00fcllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation","volume":"32","author":"Bean","year":"2019","journal-title":"Mod Pathol"},{"key":"10.6061\/clinics\/2021\/e2324_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41241-019-0075-2","article-title":"Use of uracil-DNA glycosylase enzyme to reduce DNA-related artifacts from formalin-fixed and paraffin-embedded tissues in diagnostic routine","volume":"39","author":"Berra","year":"2019","journal-title":"Appl Cancer Res"},{"issue":"11","key":"10.6061\/clinics\/2021\/e2324_bib20","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"issue":"10","key":"10.6061\/clinics\/2021\/e2324_bib21","first-page":"1453","article-title":"Next Generation Sequencing in Clinical Oncology: Applications, Challenges and Promises: A Review Article","volume":"47","author":"Shabani Azim","year":"2018","journal-title":"Iran J Public Health"},{"issue":"4","key":"10.6061\/clinics\/2021\/e2324_bib22","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cell.2018.07.034","article-title":"Comprehensive Characterization of Cancer Driver Genes and Mutations","volume":"174","author":"Bailey","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.6061\/clinics\/2021\/e2324_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/cancers12010093","article-title":"PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis","volume":"12","author":"Alqahtani","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"5670","key":"10.6061\/clinics\/2021\/e2324_bib24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1126\/science.1096502","article-title":"High frequency of mutations of the PIK3CA gene in human cancers","volume":"304","author":"Samuels","year":"2004","journal-title":"Science"},{"issue":"5","key":"10.6061\/clinics\/2021\/e2324_bib25","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1158\/1078-0432.CCR-16-2149","article-title":"Potential Targets\u2019 Analysis Reveals Dual PI3K\/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative","volume":"23","author":"Cuppens","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"26","key":"10.6061\/clinics\/2021\/e2324_bib26","doi-asserted-by":"crossref","first-page":"10746","DOI":"10.1073\/pnas.0811817106","article-title":"Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1","volume":"106","author":"Ueda","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.6061\/clinics\/2021\/e2324_bib27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/ijms19010052","article-title":"Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells","volume":"19","author":"de Almeida","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.6061\/clinics\/2021\/e2324_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2012.02.009","article-title":"Searching for molecular targets in sarcoma","volume":"84","author":"Teicher","year":"2012","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.6061\/clinics\/2021\/e2324_bib29","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/PGP.0000000000000353","article-title":"Androgen Receptor Expression in Endometrial Stromal Sarcoma: Correlation With Clinicopathologic Features","volume":"36","author":"Roy","year":"2017","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"10.6061\/clinics\/2021\/e2324_bib30","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.3802\/jgo.2018.29.e30","article-title":"Androgen receptor as a prognostic biomarker and therapeutic target in uterine leiomyosarcoma","volume":"29","author":"Baek","year":"2018","journal-title":"J Gynecol Oncol"},{"issue":"9","key":"10.6061\/clinics\/2021\/e2324_bib31","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/jog.14037","article-title":"Case of leiomyosarcoma arising from subserosal leiomyoma","volume":"45","author":"Yamaguchi","year":"2019","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"10.6061\/clinics\/2021\/e2324_bib32","article-title":"Genetic and Epigenetic Features in Uterine Smooth Muscle Tumors: An Update","volume":"4","author":"dos Anjos","year":"2019","journal-title":"Clin Oncol"},{"key":"10.6061\/clinics\/2021\/e2324_bib33","author":"National Center for Biotechnology Information"},{"issue":"12","key":"10.6061\/clinics\/2021\/e2324_bib34","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41431-017-0023-0","article-title":"Patients with a Kabuki syndrome phenotype demonstrate DNA methylation abnormalities","volume":"25","author":"Sobreira","year":"2017","journal-title":"Eur J Hum Genet"},{"issue":"D1","key":"10.6061\/clinics\/2021\/e2324_bib35","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the Catalogue Of Somatic Mutations In Cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"10.6061\/clinics\/2021\/e2324_bib36","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00109-016-1395-2","article-title":"Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer","volume":"94","author":"Er","year":"2016","journal-title":"J Mol Med"},{"issue":"6","key":"10.6061\/clinics\/2021\/e2324_bib37","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/ijc.21507","article-title":"Somatic mutations of the ERBB4 kinase domain in human cancers","volume":"118","author":"Soung","year":"2006","journal-title":"Int J Cancer"},{"issue":"1","key":"10.6061\/clinics\/2021\/e2324_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2217\/fon.09.144","article-title":"Potential of ErbB4 antibodies for cancer therapy","volume":"6","author":"Hollm\u00e9n","year":"2010","journal-title":"Future Oncol"},{"issue":"21","key":"10.6061\/clinics\/2021\/e2324_bib39","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2217\/fon-2018-0006","article-title":"An overview of meningiomas","volume":"14","author":"Buerki","year":"2018","journal-title":"Future Oncol"},{"issue":"5","key":"10.6061\/clinics\/2021\/e2324_bib40","first-page":"837","article-title":"The role of oncogenic Notch2 signaling in cancer: a novel therapeutic target","volume":"9","author":"Xiu","year":"2019","journal-title":"Am J Cancer Res"},{"key":"10.6061\/clinics\/2021\/e2324_bib41","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.pharmthera.2019.03.010","article-title":"Prevalence and role of HER2 mutations in cancer","volume":"199","author":"Cocco","year":"2019","journal-title":"Pharmacol Ther"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222000886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222000886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:07:21Z","timestamp":1761721641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222000886"},"secondary":[{"URL":"https:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1807-59322021000100212&lng=en&nrm=iso","label":"SCIELO"},{"URL":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7798418\/","label":"PMC"},{"URL":"https:\/\/www.clinicsjournal.com\/article\/the-mutational-repertoire-of-uterine-sarcomas-and-carcinosarcomas-in-a-brazilian-cohort-a-preliminary-study\/","label":"CLINICS"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":41,"alternative-id":["S1807593222000886"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2021\/e2324","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mutational repertoire of uterine sarcomas and carcinosarcomas in a Brazilian cohort: A preliminary study","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2021\/e2324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}],"article-number":"e2324"}}